DUBLIN, Dec. 11, 2014 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/65hpmd/inhaled_asthma) has announced the addition of the "Inhaled Asthma Therapeutics" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
Asthma continues to be a health segment with significant incidence and morbidity. There has been significant interest directed toward the development easier-to-use inhalers, primarily because a large segment of the population of asthma sufferers are children or elderly patients.
The new generation of oral asthma inhalers incorporates features and design elements that address this initiative, enabling devices that are more user-friendly and safe, and in the process support the parallel goal of improved compliance. Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods.
Highlights
- Analyzes therapeutic drugs and pipeline candidates delivered via oral inhalers for treating asthma
- Assesses inhalation device technology for commercial and development-stage devices, and evaluates product technology issues and evolving market factors
- Provides detailed assessments of inhaled drug targeted disease segments, growth prospects and market potential
- Provides market data and forecasts for inhaled asthma therapeutic drugs to 2020
- Profiles inhaled drug product market participants, their technology, product development activity, and business strategies
- Evaluates the impact of economic, technology, and regulatory factors on inhaled drug companies and their alliance partners
Key Topics Covered:
Executive Summary
Asthma Therapeutics Market Dynamics
- Devices, Formulations and Market Evolution
- Established Therapeutic Targets
- Prescribing Trends
- Therapeutic Strategies
- Indications, Dosing and Patient Compliance
- Factors Driving Growth
Inhalation Technology & Product Development Factors
- Drug Formulations & Formulation Technologies
- Inhalation Device Design Factors
- Dry Powder Inhalers
- Metered Dose Inhalers
- Nebulizers
- Dose Reproducibility
- Active Compound Stability
- Emerging Device Technologies
Asthma Inhaler Design Factors
- Dose Packaging
- Novel Formulation Technology
- Pre-inspiry Technology
- User Confirmation/Feedback/Disease Management
- Embedded Electronics
- Combination (multidrug) Inhalers
Inhaled Asthma Product Analysis, Market Data & Forecasts
- Corticosteroids
- Brohchodilators
- Short-acting B2 Agonists
- Long-acting B2 Agonists
- Anticholinergics
- Mast Cell Stabilizers
- Multidrug Inhalers
- Other Important/Emerging Drug Classes
Market Factors
- Regulations and Standards
- Clinical Trials
- Healthcare Economics
- Managed Care and Payor Initiatives
Company Profiles
For more information visit http://www.researchandmarkets.com/research/65hpmd/inhaled_asthma
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article